Volume 9, Number 6—June 2003
Research
Children with Respiratory Disease Associated with Metapneumovirus in Hong Kong
Table 2
Characteristics | HMPV |
RSV |
Influenza A |
p valueb |
||
---|---|---|---|---|---|---|
No. positive/ total (%) | No. positive/ total (%) | No. positive/ total (%) | Overall | HMPV vs. RSV | HMPV vs. influenza A | |
Influenzalike illness in family contact |
10/19 (52.6) |
7/29 (24.1) |
19/24 (79.1) |
0.0003 |
0.29 |
0.37 |
Influenzalike illness in adult family contact |
5/19 (26.3) |
4/29 (13.8) |
13/24 (54.2) |
0.005 |
0.68 |
0.45 |
Febrile seizures |
5/32 (15.6) |
1/32 (3.1) |
3/32 (9.4) |
0.229 |
— |
— |
Congested pharynx |
12/32 (37.5) |
11/32 (34.4) |
11/32 (34.4) |
0.955 |
— |
— |
Rash |
4/32 (12.5) |
1/32 (3.1) |
4/32 (12.5) |
0.331 |
— |
— |
Enlarged liver |
2/32 (6.3) |
0/32 (0.0) |
4/32 (12.5) |
0.331 |
— |
— |
Otitis media |
4/32 (12.5) |
0/32 (0.0) |
0/32 (0.0) |
0.201 |
— |
— |
Diarrhea |
2/32 (6.3) |
1/32 (3.1) |
3/32 (9.4) |
0.586 |
— |
— |
Crepitations |
18/32 (56.3) |
14/32 (43.8) |
3/32 (9.4) |
0.0003 |
0.50 |
0.0007 |
Wheezing |
9/32 (28.1) |
12/32 (37.5) |
2/32 (6.3) |
0.0109 |
0.60 |
0.04 |
Asthma exacerbation |
6/32 (18.8) |
2/32 (6.3) |
2/32 (6.3) |
0.167 |
— |
— |
Acute bronchiolitis |
3/32 (9.4) |
10/32 (31.3) |
0/32 (0.0) |
0.0009 |
0.13 |
0.37 |
Pneumonia |
12/32 (37.5) |
5/32 (15.6) |
1/32 (3.1) |
0.0017 |
0.30 |
0.009 |
Abnormal chest x-ray |
17/25 (68.0) |
11/18 (61.1) |
1/17 (5.9) |
0.0002 |
0.89 |
0.0002 |
Lymphopenia (<1.5 x 109/L) |
9/31 (29.0) |
2/27 (7.4) |
12/29 (41.4) |
0.017 |
0.34 |
1.0 |
Neutropenia (ANC<1 x 109/L) |
2/31 (6.5) |
0/27 (0.0) |
4/29 (13.8) |
0.125 |
— |
— |
Elevated transaminases | 2/15 (13.3) | 0/5 (0.0) | 3/11 (27.3) | 0.357 | — | — |
aHMPV, human metapneumovirus; RSV, respiratory syncytial virus.
bp values performed using McNemar chi-square test.
Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.